O'Callaghan Adrian, Mastracci Tara M, Greenberg Roy K, Eagleton Matthew J, Bena James, Kuramochi Yuki
Department of Vascular and Endovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Vascular and Endovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
J Vasc Surg. 2014 Oct;60(4):914-20. doi: 10.1016/j.jvs.2013.12.053. Epub 2014 Jul 1.
Endovascular options for the treatment of proximal thoracic and arch disease have evolved over the years. In this manuscript, we review the midterm results of fenestrated compared with chimney configurations for proximal aortic aneurysm disease.
We performed an analysis of all patients with chimney grafts or custom fenestrated endografts used for treatment of proximal thoracic aneurysm disease (involving the supra-aortic trunk vessels) presenting to our institution between 2004 and 2013. Patients were identified by retrospective chart review and through the prospective database (National Institutes of Health study number NCT00583050). Details of devices placed, intraoperative details, and measurements from postoperative imaging were included in the analysis. The primary outcomes of interest were long-term freedom from branch stent complications and freedom from proximal endoleak, but we also included perioperative events, in-hospital mortality, and requirement for secondary interventions in our review. The log-rank test (Mantel-Cox) was used to compare survival data. Student t-test (two tailed) and Fisher exact test (two tailed) were used for continuous and categorical data, respectively.
Of 767 patients who underwent thoracic endovascular repair from January 2004 to February 2013, 33 satisfied the inclusion criteria (4%): 18 of 33 noncustom and 15 of 33 custom graft designs. Overall, the rate of technical success was 97%. There were four branch stent-related problems in the follow-up period, one of 15 (7%) in the custom group and three of 18 (17%) in the noncustom group. There were three proximal sealing failures in the immediate postoperative and follow-up period, one of 15 (7%) in the custom group and two of 18 (11%) in the noncustom group. Overall, 10 patients underwent secondary procedures, four of 15 (27%) in the custom group and six of 18 (33%) in the noncustom group.
Although they are technically feasible, both custom fenestrated endografts and chimney repairs for proximal thoracic disease involving the supra-aortic trunk vessels suffer from failures in intermediate follow-up, with a trend toward better long-term outcomes for custom devices. More work is needed to develop durable devices for this anatomic territory in the future.
多年来,治疗胸段近端和主动脉弓疾病的血管内治疗方法不断发展。在本论文中,我们回顾了带开窗覆膜支架与烟囱式覆膜支架治疗近端主动脉瘤疾病的中期结果。
我们对2004年至2013年间在我院接受治疗的所有使用烟囱式覆膜支架或定制带开窗覆膜支架治疗胸段近端动脉瘤疾病(累及主动脉弓上血管)的患者进行了分析。通过回顾性病历审查和前瞻性数据库(美国国立卫生研究院研究编号NCT00583050)确定患者。分析内容包括所放置器械的详细信息、术中详细情况以及术后影像学测量结果。主要关注的结局是分支支架并发症的长期无发生以及近端内漏的无发生,但我们在回顾中也纳入了围手术期事件、住院死亡率以及二次干预的需求。采用对数秩检验(Mantel-Cox)比较生存数据。分别使用学生t检验(双侧)和Fisher精确检验(双侧)分析连续数据和分类数据。
在2004年1月至2013年2月接受胸段血管内修复的767例患者中,33例符合纳入标准(4%):33例非定制设计中有18例,33例定制设计中有15例。总体而言,技术成功率为97%。随访期间有4例与分支支架相关的问题,定制组15例中有1例(7%),非定制组18例中有3例(17%)。术后即刻和随访期间有3例近端密封失败,定制组15例中有1例(7%),非定制组18例中有2例(11%)。总体而言,10例患者接受了二次手术,定制组15例中有4例(27%),非定制组18例中有6例(33%)。
尽管技术上可行,但定制带开窗覆膜支架和烟囱式修复治疗累及主动脉弓上血管的胸段近端疾病在中期随访中均存在失败情况,定制器械的长期结局有更好的趋势。未来需要开展更多工作来开发适用于该解剖区域的耐用器械。